![]() |
市場調查報告書
商品編碼
1818063
全球藥用飼料添加劑市場:預測至2032年-按產品類型、動物種類、劑型、分銷管道、最終用戶和地區進行分析Medicated Feed Additives Market Forecasts to 2032 - Global Analysis By Product Type, Animal Type, Formulation, Distribution Channel, End User, and By Geography |
根據 Stratistics MRC 的數據,全球藥物飼料添加劑市場預計在 2025 年達到 168 億美元,到 2032 年將達到 256 億美元,預測期內的複合年成長率為 6.2%。
藥用飼料添加劑是添加到牲畜飼料中,用於維持牲畜和家禽健康、預防疾病或治療特定疾病的化合物。藥用飼料添加劑兼具營養和治療功效,能夠促進生長、提高飼料效率和動物整體健康。這些添加劑包括抗生素、抗寄生蟲藥、維生素和礦物質,旨在維持牲畜健康、預防感染疾病並提高生產力。
根據歐洲食品安全局(EFSA)估計,歐盟國家每年報告32萬例經由食物傳染疾病和通用感染疾病,這可能會對藥用飼料添加劑市場的收益成長產生正面影響。
驅動程式
對動物健康和福利的日益關注
人們對動物健康和倫理治療意識的不斷增強,推動了對藥物飼料添加劑的需求。這些添加劑在預防疾病爆發、增強免疫力和提高動物整體生產力方面發揮關鍵作用。消費者和監管機構日益嚴格的審查,促使生產者優先考慮注重動物福利的解決方案,以減少對抗生素的依賴。藥物添加劑在提供針對性治療益處的同時,也支持永續的農業實踐。對更高品質肉類和乳製品的需求也推動了它們在商業農場的應用。隨著全球動物福利標準的收緊,這些添加劑正成為負責任畜牧業的必備工具。
供應鏈中斷和價格波動
藥用飼料添加劑面臨供應鏈不穩定和原料成本波動的挑戰。活性成分、維生素和礦物質採購中斷可能會導致生產延誤並造成庫存緊張。藥物化合物和飼料化學品的價格波動會影響盈利和採購計畫。這種不確定性對於緩衝能力有限的小型製造商來說尤其成問題。監管延遲和進口限制進一步加劇了物流複雜化,尤其是在新興市場。總體而言,供應鏈脆弱性和不可預測的成本仍然是市場持續成長的主要障礙。
精準牲畜營養的興起
精準牲畜營養的轉變正在為藥物飼料添加劑開闢新的成長途徑。酪農和畜牧生產者擴大採用數據主導的方法,根據品種、年齡和健康狀況最佳化飼料配方。這一趨勢推動了針對性添加劑的使用,這些添加劑能夠在不過量的情況下提供治療效果。飼料技術和診斷技術的創新使得劑量更精準,健康狀況更佳。隨著永續性和效率成為畜牧生產的核心,精準營養在家禽、豬和反芻動物領域日益普及。藥物添加劑有望從飼料策略的這一演變中獲益。
與替代品的競爭
益生菌、植物性成分和有機飼料補充劑等替代性健康解決方案正給市場帶來壓力。由於消費者對天然、無抗生素畜產品的需求不斷成長,這些替代品越來越受歡迎。有利於非藥物介入的監管變化也影響購買決策。在某些情況下,生產商正在轉向整體健康管理策略,以減少對合成添加劑的依賴。潔淨標示動物產品日益成長的吸引力對傳統的藥物飼料解決方案構成了直接挑戰。因此,來自替代品的競爭正在改變市場格局並迫使企業進行創新。
COVID-19的影響
疫情最初導致供應鏈中斷和農場活動減少,擾亂了藥物飼料添加劑市場。停工影響了飼料生產、獸醫服務和分銷網路,造成了暫時的挫折。然而,家禽和酪農等關鍵產業的需求有助於緩解疫情的影響。這場危機也凸顯了疾病預防和生物安全的重要性,提升了藥物添加物的價值。隨著復工復產,生產商優先考慮具有韌性、以健康為中心的飼養策略,以降低未來的風險。
抗生素市場預計將成為預測期內最大的市場
預計抗生素領域將在預測期內佔據最大的市場佔有率,這主要得益於對動物健康、生長率和飼料轉換效率提升的需求。控制釋放和微膠囊技術等技術創新正在提高給藥精度和藥物穩定性。精準飼餵和益生菌的整合應用正逐漸成為降低抗生素依賴的趨勢。監管變化,尤其是在歐洲和亞洲,也推動了配方改革和永續替代品的研發,因為製造商正在適應更嚴格的獸醫合規性和不斷發展的畜牧管理標準。
預測期內飼料製造商預計將以最高複合年成長率成長
飼料製造業專注於動物健康、生產性能和監管合規,預計在預測期內將達到最高成長率。奈米配方和精準輸送系統的突破性進展正在提高添加劑效率並最大限度地減少資源損失。植物源性成分和酵素基解決方案的顯著轉變正在取代傳統抗生素。近期趨勢,包括合作研發計劃、數位可追溯性工具的採用以及與日益嚴格的法規相適應的再製造工作(尤其是在歐洲和亞太地區),正在推動飼料生產策略的創新和合規性。
由於動物性蛋白質消費量增加、畜牧管理實踐改進以及疾病預防意識不斷增強,預計亞太地區將在預測期內佔據最大市場佔有率。奈米遞送和精準劑量技術的創新正在提升添加劑的性能。天然酵素解決方案取代傳統抗生素的趨勢明顯。嘉吉和碩騰等領先公司正在加強研發力度,而印度和中國日益嚴格的法規正在推動飼料配方改革和數位追溯系統的實施,以確保合規並最佳化飼料性能。
預計北美將在預測期內實現最高的複合年成長率,這得益於消費者對無抗生素肉類的需求不斷成長、美國食品藥品監督管理局(FDA)監管力度的加強以及人們對動物健康的日益關注。免疫支持和腸道靶向技術的進步正在提高添加劑的有效性。市場正轉向天然和有機飼料,這反映了人們對永續性的偏好。碩騰和ADM等主要企業正在擴大其研發活動,數位可追溯平台也越來越受歡迎,有助於提高整個飼料供應鏈的合規性和透明度。
According to Stratistics MRC, the Global Medicated Feed Additives Market is accounted for $16.80 billion in 2025 and is expected to reach $25.60 billion by 2032 growing at a CAGR of 6.2% during the forecast period. Medicated Feed Additives are compounds added to animal feed to support health, prevent illnesses, or treat certain conditions in livestock and poultry. They provide both nutritional and therapeutic benefits, boosting growth, feed efficiency, and overall animal wellness. These additives can include antibiotics, antiparasitic agents, vitamins, or minerals, aimed at maintaining animal health, preventing infections, and enhancing productivity, thereby promoting effective livestock management and sustainable farming practices.
According to estimates from the European Food Safety Authority (EFSA), 320,000 food-borne and zoonotic diseases are reported annually in EU nations. This will affect the growth of the Medicated Feed Additives market revenue positively.
Driver
Growing concern for animal health and welfare
Heightened awareness around livestock health and ethical treatment is fueling demand for medicated feed additives. These additives play a vital role in preventing disease outbreaks, improving immunity, and enhancing overall animal productivity. With increasing scrutiny from consumers and regulators, producers are prioritizing welfare-friendly solutions that reduce reliance on antibiotics. Medicated additives offer targeted therapeutic benefits while supporting sustainable farming practices. The push for higher-quality meat and dairy products is also encouraging adoption across commercial farms. As welfare standards tighten globally, these additives are becoming essential tools for responsible animal husbandry.
Supply chain disruptions and price volatility
The medicated feed additives faces challenges from unstable supply chains and fluctuating raw material costs. Disruptions in sourcing active ingredients, vitamins, and minerals can delay production and strain inventory levels. Price swings in pharmaceutical compounds and feed-grade chemicals impact profitability and procurement planning. These uncertainties are particularly problematic for smaller manufacturers with limited buffer capacity. Regulatory delays and import restrictions further complicate logistics, especially in emerging markets. Overall, supply chain fragility and cost unpredictability remain key barriers to consistent market growth.
Rise of precision animal nutrition
The shift toward precision livestock nutrition is unlocking new growth avenues for medicated feed additives. Farmers and integrators are increasingly adopting data-driven approaches to optimize feed formulations based on species, age, and health status. This trend supports the use of targeted additives that deliver therapeutic benefits without overuse. Innovations in feed technology and diagnostics are enabling more accurate dosing and better health outcomes. As sustainability and efficiency become central to animal production, precision nutrition is gaining traction across poultry, swine, and ruminant sectors. Medicated additives are well-positioned to benefit from this evolution in feed strategy.
Competition from substitutes
The market is under pressure from alternative health solutions such as probiotics, phytogenics, and organic feed supplements. These substitutes are gaining popularity due to rising consumer demand for antibiotic-free and natural livestock products. Regulatory shifts favoring non-medicated interventions are also influencing purchasing decisions. In some cases, producers are switching to holistic health management strategies that reduce reliance on synthetic additives. The growing appeal of clean-label animal products poses a direct challenge to traditional medicated feed solutions. As a result, competition from substitutes is reshaping the market landscape and forcing innovation.
Covid-19 Impact
The pandemic initially disrupted the medicated feed additives market through supply chain breakdowns and reduced farm-level activity. Lockdowns affected feed production, veterinary services, and distribution networks, leading to temporary slowdowns. However, demand from essential sectors like poultry and dairy helped cushion the impact. The crisis underscored the importance of disease prevention and biosecurity, reinforcing the value of medicated additives. As operations resumed, producers prioritized resilient and health-focused feed strategies to mitigate future risks.
The antibiotics segment is expected to be the largest during the forecast period
The antibiotics segment is expected to account for the largest market share during the forecast period, propelled by the need to boost animal health, growth rates, and feed conversion efficiency. Innovations like controlled-release and microencapsulation technologies are enhancing delivery precision and drug stability. There's growing momentum around precision feeding and probiotic integration to curb antibiotic dependence. Regulatory shifts especially in Europe and Asia are catalyzing reformulations and sustainable alternatives, as manufacturers adapt to stricter veterinary compliance and evolving standards in livestock management.
The feed manufacturers segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the feed manufacturers segment is predicted to witness the highest growth rate, driven by focusing on livestock health, performance, and regulatory alignment. Breakthroughs in nano-formulations and precision delivery systems are boosting additive efficiency and minimizing resource loss. A notable shift toward phytogenic ingredients and enzyme-based solutions is replacing traditional antibiotics. Recent developments include collaborative R&D initiatives, adoption of digital tracking tools, and reformulation efforts tailored to meet tightening regulations especially across Europe and Asia-Pacific driving innovation and compliance in feed production strategies.
During the forecast period, the Asia Pacific region is expected to hold the largest market share due to rising animal protein consumption, intensified livestock operations, and heightened awareness of disease prevention. Innovations in nano-delivery and precision dosing technologies are improving additive performance. There's a clear trend toward natural, enzyme-based solutions replacing conventional antibiotics. Major players like Cargill and Zoetis are ramping up R&D, while stricter regulations in India and China are prompting reformulations and the adoption of digital traceability systems to ensure compliance and optimize feed outcomes.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, fueled by increasing consumer demand for antibiotic-free meat, tighter FDA oversight, and rising attention to animal health. Advances in immune-supporting and gut-targeted technologies are improving additive effectiveness. The market is shifting toward natural and organic feed options, reflecting sustainability-driven preferences. Leading companies like Zoetis and ADM are expanding research efforts, while digital traceability platforms are gaining traction to support regulatory compliance and enhance transparency across the feed supply chain.
Key players in the market
Some of the key players profiled in the Medicated Feed Additives Market include Phibro Animal Health Corporation, Novus International, Zoetis Inc., De Heus Animal Nutrition, Elanco Animal Health, Land O'Lakes Inc., Cargill Incorporated, Nutreco N.V., Archer Daniels Midland Company (ADM), BASF SE, Alltech Inc., CHS Inc., Kemin Industries, Evonik Industries AG, and Adisseo.
In June 2025, Zoetis Inc. has launched AI Masses, the newest addition to the Vetscan Imagyst(R) analyzer. AI Masses detects potentially neoplastic cells with accuracy1,2, supporting veterinary professionals to make informed decisions - streamlining diagnoses and clinic workflows. The newest indication enhances Zoetis' digital cytology offering by enabling fast, accurate1,2 AI analysis of lymph node and skin/subcutaneous masses, delivering results in minutes.
In June 2025, De Heus Animal Nutrition announces the acquisition of Voeders Huys, a well-established Belgian feed producer with production sites in Bruges (Belgium) and Northern France. This strategic move strengthens De Heus' position in Western Europe, a key region where the company has already experienced significant commercial growth and will now also produce locally.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.